CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 84 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 1,200 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $6 | +50.0% | 1,200 | -7.7% | 0.00% | – |
| Q1 2023 | $4 | -85.7% | 1,300 | -64.9% | 0.00% | -100.0% |
| Q4 2022 | $28 | -99.9% | 3,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $29,000 | -49.1% | 3,700 | -5.1% | 0.00% | -50.0% |
| Q2 2022 | $57,000 | +58.3% | 3,900 | +50.0% | 0.00% | +100.0% |
| Q1 2022 | $36,000 | -92.0% | 2,600 | -95.0% | 0.00% | -90.0% |
| Q4 2021 | $451,000 | +1.1% | 52,340 | +138.8% | 0.02% | 0.0% |
| Q3 2021 | $446,000 | -65.0% | 21,914 | -76.9% | 0.02% | -66.1% |
| Q2 2021 | $1,275,000 | -25.4% | 95,036 | +130.1% | 0.06% | -29.8% |
| Q1 2021 | $1,709,000 | -36.8% | 41,300 | -53.0% | 0.08% | -34.9% |
| Q4 2020 | $2,706,000 | +68.0% | 87,900 | +17.2% | 0.13% | +30.3% |
| Q3 2020 | $1,611,000 | – | 75,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |